2017
DOI: 10.1038/s41598-017-06395-6
|View full text |Cite
|
Sign up to set email alerts
|

Ryanodine receptors are part of the myospryn complex in cardiac muscle

Abstract: The Cardiomyopathy–associated gene 5 (Cmya5) encodes myospryn, a large tripartite motif (TRIM)-related protein found predominantly in cardiac and skeletal muscle. Cmya5 is an expression biomarker for a number of diseases affecting striated muscle and may also be a schizophrenia risk gene. To further understand the function of myospryn in striated muscle, we searched for additional myospryn paralogs. Here we identify a novel muscle-expressed TRIM-related protein minispryn, encoded by Fsd2, that has extensive se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
48
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(55 citation statements)
references
References 62 publications
6
48
0
1
Order By: Relevance
“…To identify the potential selection markers for reprogramming or refractory populations, we focused on those genes repeatedly ranked at the top of the DEG list (p < 0.05 at each time point; Figure 7D, highlight in red dots; Table S4). Among the genes highly expressed in reprogramming cells (Figure 7E), we found several makers already known in heart, like cardiomyopathy-associated 5 (CMYA5) encoding MYOSPRYN (Benson et al, 2017;Durham et al, 2006), crystallin alpha B (CRYAB or HSPB5) and heat shock protein family B (small) member 2 (HSPB2) (Sugiyama et al, 2000). Transforming growth factor beta 3 (TGFB3), another potential marker for reprogramming cells, exhibited increasing See also Figure S7 and Tables S4 and S5.…”
Section: Comparative Analyses Between Reprogramming and Refractory Routesmentioning
confidence: 86%
“…To identify the potential selection markers for reprogramming or refractory populations, we focused on those genes repeatedly ranked at the top of the DEG list (p < 0.05 at each time point; Figure 7D, highlight in red dots; Table S4). Among the genes highly expressed in reprogramming cells (Figure 7E), we found several makers already known in heart, like cardiomyopathy-associated 5 (CMYA5) encoding MYOSPRYN (Benson et al, 2017;Durham et al, 2006), crystallin alpha B (CRYAB or HSPB5) and heat shock protein family B (small) member 2 (HSPB2) (Sugiyama et al, 2000). Transforming growth factor beta 3 (TGFB3), another potential marker for reprogramming cells, exhibited increasing See also Figure S7 and Tables S4 and S5.…”
Section: Comparative Analyses Between Reprogramming and Refractory Routesmentioning
confidence: 86%
“…Moreover, a recently shown association of RyR2a with the desmin-associated protein myospryn (CMYA5, cardiomyopathy-associated 5), a novel tripartite motif family (TRIM)-like protein, demonstrated in addition to VDAC an indirect way of desmin association to the SR of cardiomyocytes (Benson et al 2017). The desmin-myospryn interaction is important for perinuclear and lysosomal localization of myospryn (see below) (Kouloumenta et al 2007).…”
Section: Desmin and The Contractile Apparatus-sarcomeres/myofibrilsmentioning
confidence: 99%
“…Across the hGWAS set of 40 genes, comparative heart rate analysis showed statistically significant heart rate phenotypes in a total of 16 genes ( Fig 3B). The five positive controls, known to play key roles in heart functions such as cardiac contraction (TTN and NACA) and heart rate regulation (CASQ2, Beyond known cardiac genes, we revealed new genes linked to various biological functions (CCDC141, GIGYF1, HOMEZ, MYRF, SMG6, CMYA5, CNOT1, SLC17A3, TRAPPC12, SSPO and PADI4) which up to now, had little to no experimental evidence in cardiac function (Rathjens et al 2020;Benson et al 2017;Yamaguchi et al 2018;Elmen et al 2020).…”
Section: Resultsmentioning
confidence: 98%
“…clearly responded in the assay. Beyond known cardiac genes, we revealed new genes linked to various biological functions (CCDC141, GIGYF1, HOMEZ, MYRF, SMG6, CMYA5, CNOT1, SLC17A3, TRAPPC12, SSPO and PADI4) which up to now, had little to no experimental evidence in cardiac function (Rathjens et al 2020;Benson et al 2017;Yamaguchi et al 2018;Elmen et al 2020).…”
Section: Resultsmentioning
confidence: 99%